Global Chronic Liver Diseases Therapeutics Market Is Analysed And Market Size Information Is Provided By Regions

The liver is the largest organ of the body which performs a wide variety of roles that include converting food into energy, creating bile for proper digestion of food, and detoxifying alcohol and poison from the blood. There are several kinds of liver diseases such as hepatitis A, hepatitis B, and hepatitis C; liver fibrosis, liver cancer; fatty liver disease and cirrhosis; hemochromatosis, and Wilson's disease.

However, side effects and risks associated with liver disease therapeutics are expected to hinder growth of the global chronic liver disease therapeutics market. The side effects associated with the use of liver therapeutics are nausea, headache, fever loss of appetite, and drug-induced liver disease. Moreover, availability of alternate treatment procedures such as organ transplantation and liver resection are also expected to limit growth of the market.

 

The global chronic liver diseases therapeutics market is estimated to be valued at US$ 12.8 Bn in 2020 and is expected to exhibit a CAGR of 9.7% during the forecast period (2020-2027).

 

Global Chronic Liver Diseases Therapeutics Market - Impact of Coronavirus (Covid-19) Pandemic
The spread of coronavirus has negatively impacted the global chronic liver disease therapeutics market. The outbreak of this virus has hindered the growth of the global market. The U.S has the highest number of corona patients which is expected to impact the country’s economic condition. The U.S is high potential market for the pharmaceuticals industry, and the economic slowdown of the U.S economy is likely to impact the market for pharmaceutical drugs. Similarly, markets in India, Brazil, Russia and other economies are also suffering due to Covid-19 attack that is expected to impact on lowering the pharmaceutical growth.

 

To know the latest trends and insights prevalent in this market, click the link below: https://www.businesswire.com/news/home/20200730005374/en/Global-Chronic-Liver-Disease-Therapeutics-Market-to-Surpass-US-24.9-Billion-by-2027-Says-Coherent-Market-Insights